Asia Pacific to emerge as Fastest Growing Heparin Market Globally with 8.0% CAGR till 2023: Transparency Market Research

According to a new market report published by Transparency Market Research “Heparin Market (By Product: Unfractionated Heparin, Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin; By Geography: North America, Europe, Asia Pacific and Rest of the World) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015–2023” the global heparin market was valued at USD 8,297.3 million in 2014 and is estimated to reach USD 14,391.8 million by 2023 growing with 6.3% CAGR from 2015 to 2023.

Download free exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=803

Heparin is a widely used anticoagulant for the treatment and prevention of thromboembolic disorders. Its importance as an anticoagulant has been well established by its effectiveness, rapid onset of action, ease of laboratory monitoring and low cost. Most commercial forms of heparin are extracted from porcine intestine or bovine lungs. Heparin is preferably administered intravenously or subcutaneously as against oral mode to overcome its low absorption in human intestine.

Heparin is an injectable blood thinner, utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also employed as part of the treatment of unstable angina and myocardial infarction. The increasing incidence of coagulation disorders is propelling the demand for heparin significantly across the world.

The global heparin market has been analyzed on the basis of product in this research report. Ultra-low molecular weight heparin (ULMWHs), low molecular weight heparin (LMWHs), and unfractionated heparin are the major products available in the worldwide heparin market. ULMWHs has been the most commonly used heparin over the past decade. However, the increasing overall cost of ULMWHs is likely to hamper the growth of this market segment in the near future, states the research report.

View exclusive Global strategic Business report:http://www.transparencymarketresearch.com/heparin-market.html

The report also studies the global heparin market on the basis of its regional spread. According to the study, Europe, North America, Asia Pacific, and the Rest of the World are the prime regional markets for heparin.

Europe dominated the global heparin market in 2014, while North America occupied the second position. The rising incidence of coagulation disorders in North America and Europe is driving these regional markets significantly.

In addition to this, the growing prevalence of deep vein thrombosis (DVT), spurred by the rapid increase in the geriatric population, leading to cancer, heart failure, and obesity is likely to drive the demand for heparin in these regions over the forecast period, notes the research study.

The heparin markets in Asia Pacific and the Rest of the World are also expected to exhibit healthy growth during the forecast period on account of the presence of a largely untapped market. Analysts at TMR anticipate the economic growth, the infrastructural development in the healthcare sector, and the rising number of surgical procedures in these regions to fuel the demand for heparin significantly in the coming years.

Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, Fresenius Kabi AG, Mylan N.V., Sanofi S.A., Pfizer Inc., and Syntex S.A. are some of the key participants in the global heparin market profiled in the report.

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.